209 related articles for article (PubMed ID: 36130148)
1. Emerging Therapies for the Management of Richter Transformation.
Smyth E; Eyre TA; Cheah CY
J Clin Oncol; 2023 Jan; 41(2):395-409. PubMed ID: 36130148
[TBL] [Abstract][Full Text] [Related]
2. Accelerated Chronic Lymphocytic Leukemia and Richter Transformation in the Era of Novel Agents.
Levy Yurkovski I; Tadmor T
Acta Haematol; 2024; 147(1):73-83. PubMed ID: 37666234
[TBL] [Abstract][Full Text] [Related]
3. Practical Management of Richter Transformation in 2023 and Beyond.
Ryan CE; Davids MS
Am Soc Clin Oncol Educ Book; 2023 Jan; 43():e390804. PubMed ID: 37141545
[TBL] [Abstract][Full Text] [Related]
4. SOHO State of the Art Updates and Next Questions | Treatment of Richter's Transformation.
Romano I; Condoluci A; Rossi D
Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):786-799. PubMed ID: 37586917
[TBL] [Abstract][Full Text] [Related]
5. Richter Transformation of Chronic Lymphocytic Leukemia-Are We Making Progress?
Audil HY; Kosydar SR; Larson DP; Parikh SA
Curr Hematol Malig Rep; 2023 Oct; 18(5):144-157. PubMed ID: 37294394
[TBL] [Abstract][Full Text] [Related]
6. Are we closer to a standard of care for Richter's syndrome? Novel treatments on the horizon.
Pham N; Coombs CC; O'Brien S
Expert Rev Hematol; 2024; 17(4-5):117-126. PubMed ID: 38693662
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Richter Transformation of Chronic Lymphocytic Leukemia in the Modern Era.
Briski R; Taylor J
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980742
[TBL] [Abstract][Full Text] [Related]
8. Richter transformation of CLL.
Jain N; Keating MJ
Expert Rev Hematol; 2016 Aug; 9(8):793-801. PubMed ID: 27351634
[TBL] [Abstract][Full Text] [Related]
9. Chronic Lymphocytic Leukemia (CLL): Biology and Therapy.
Siddiqi T
Cancer Treat Res; 2021; 181():133-149. PubMed ID: 34626359
[TBL] [Abstract][Full Text] [Related]
10. Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies.
Khan M; Siddiqi R; Thompson PA
Ann Hematol; 2018 Jan; 97(1):1-15. PubMed ID: 29063177
[TBL] [Abstract][Full Text] [Related]
11. Frontline Treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Targeted Therapy vs. Chemoimmunotherapy.
Small S; Ma S
Curr Hematol Malig Rep; 2021 Aug; 16(4):325-335. PubMed ID: 34021874
[TBL] [Abstract][Full Text] [Related]
12. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
13. Richter transformation-is there light at the end of this tunnel?
Eyre TA
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):427-432. PubMed ID: 38066897
[TBL] [Abstract][Full Text] [Related]
14. Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformation.
Kanagal-Shamanna R; Jain P; Patel KP; Routbort M; Bueso-Ramos C; Alhalouli T; Khoury JD; Luthra R; Ferrajoli A; Keating M; Jain N; Burger J; Estrov Z; Wierda W; Kantarjian HM; Medeiros LJ
Cancer; 2019 Feb; 125(4):559-574. PubMed ID: 30508305
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up and future direction on the management of chronic lymphocytic leukemia/small lymphocytic leukemia.
Hanna KS; Fijalka A; Watson I; Brown O; Ojulu A
J Oncol Pharm Pract; 2022 Dec; 28(8):1869-1884. PubMed ID: 35635742
[TBL] [Abstract][Full Text] [Related]
16. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.
Jamroziak K; Tadmor T; Robak T; Polliack A
Leuk Lymphoma; 2015 Jul; 56(7):1949-58. PubMed ID: 25356923
[TBL] [Abstract][Full Text] [Related]
17. Response to therapy in Richter syndrome: a systematic review with meta-analysis of early clinical trials.
Sousa-Pimenta M; Martins Â; Mariz JM; Berraondo P
Front Immunol; 2023; 14():1295293. PubMed ID: 38077330
[TBL] [Abstract][Full Text] [Related]
18. Frontline Therapy in Chronic Lymphocytic Leukemia.
Arguello-Tomas M; Albiol N; Moreno C
Acta Haematol; 2024; 147(1):47-59. PubMed ID: 37899041
[TBL] [Abstract][Full Text] [Related]
19. SOHO State of the Art Updates and Next Questions | Management of Most Difficult Cases of Chronic Lymphocytic Leukemia: Relapse After Both BTK and BCL2 Inhibition and Richter Transformation.
Burke JM
Clin Lymphoma Myeloma Leuk; 2022 Jul; 22(7):427-435. PubMed ID: 35577753
[TBL] [Abstract][Full Text] [Related]
20. Novel combination approaches with targeted agents in frontline chronic lymphocytic leukemia.
Lipsky AH; Lamanna N
Cancer; 2023 Jan; 129(1):18-31. PubMed ID: 36326285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
